Keywords: Bayer, OncoMed Pharma, Licensing, Stem cell therapeutics, Wnt pathway

Bayer signs mega-million-dollar deal with OncoMed to develop anti-cancer stem cell therapeutics

Article | 18 June 2010

Print This

It seems there is no end to the mega-dollar licensing accords that research-based drug majors are signing. The latest is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in